Posts by camerontucker
Top PBMC Suppliers for 2026: Fresh, Cryopreserved, and GMP-Grade Options Compared
Introduction Peripheral Blood Mononuclear Cells (PBMCs) are foundational to immunology, oncology, and cell therapy research. Whether they are used for functional assays, vaccine development, or discovery-stage therapeutic studies, PBMC quality directly impacts data accuracy and reproducibility. In 2026, researchers expect more than just availability. They look for documented donor screening, consistent viability, and responsive support.…
For More InformationBest Leukopak Suppliers for Cell Therapy in 2026: Pricing, Quality, and Turnaround Compared
Introduction When it comes to sourcing leukopaks for cell therapy or research, product quality is only half the story. Procurement delays, unanswered inquiries, and limited visibility can stall entire workflows. In 2026, speed and communication matter just as much as purity and yield. To help researchers, process developers, and procurement teams choose confidently, we reviewed…
For More InformationThe Donors Powering Breakthroughs in Maternal and Infant Health
Every great discovery begins with a volunteer. At CGT Global, maternal blood donors are at the heart of pregnancy and infant health research. Their contributions help scientists understand how life begins, how the body adapts during pregnancy, and how to prevent complications that still threaten mothers and babies worldwide. When someone donates maternal blood, they…
For More InformationScaling Cell & Gene Therapy Development: How CGT Global Supports Research, Clinical Trials, and Commercialization
By Joanna Wirkus, PhD From RUO to cGMP, CGT Global delivers quality, consistency, and regulatory readiness to help researchers advance therapies from discovery to patients. Executive Summary CGT Global accelerates cell and gene therapy development from discovery to commercialization. By providing rapid and reliable access to high-quality RUO and cGMP-certified materials and operating FDA- and CLIA-certified…
For More InformationMeet CGT Global’s Scientific Team: Vanessa Murillo – Supervisor, Client Scientific Associate Team
October 08, 2025 Written by: Joanna Wirkus, PhD At CGT Global, advancing scientific discoveries worldwide by delivering high-quality biospecimens starts with providing exceptional service to our clients. Today, we’re highlighting how this happens by speaking with Vanessa Murillo, a core member and leader of CGT Global’s Client Scientific Associate team. Vanessa is a Client Scientific…
For More Information5 Green Flags the FDA Looks for in CGT CMC and How to Get Them
Roughly 50 to 75 percent of FDA rejections in cell and gene therapy are not about safety or efficacy. They are due to CMC and manufacturing deficiencies. In short, most programs do not fail because the science does not work. They fail because the manufacturing story is not strong enough. (Sources: Jefferies analysis of FDA…
For More InformationBaby KJ Makes Headlines as the First Infant to Receive Personalized CRISPR Gene Editing Therapy
Written by Joanna Wirkus, PhD May 15, 2025, NPR ’s Science Friday spotlighted Baby KJ, the first infant to receive a personalized CRISPR-based gene editing treatment. The segment explored the groundbreaking therapy, the condition it aims to treat, and the collaborative effort behind this historic milestone. Here’s a summary of the key points from the…
For More InformationAlzheimer’s & Neurodegenerative Disease: A Global Challenge
Written by CGT Global Cell & Gene Therapy Is Shifting the Paradigm Recent CGT innovations are upending traditional models and opening new paths to treat or even reverse Alzheimer’s progression: 1. AAV-Based Gene Therapy (LX1001) 2. CRISPR-Engineered Microglia 3. Behavior-Reprogramming Gene Therapy (UC San Diego) 4. Stem Cells & MSC Therapies 5. iPSC TriCulture Models…
For More InformationMesenchymal Stem Cell Derived Exosomes: Revolutionizing Future Medical Treatments
Why are scientists excited about Mesenchymal Stem Cell Exosomes? Mesenchymal stem cell (MSC) exosomes are on the brink of revolutionizing future treatments for chronic diseases and injuries. These microscopic biological messengers represent a vital mechanism of cellular communication, potentially offering a biomolecular reset for human physiological processes. The Unique Capabilities of Mesenchymal Stem Cells Mesenchymal…
For More InformationCGT Global Welcomes Dr. Jerome Ritz to Its Board of Advisors, Enriching Knowledge of Cellular Therapies and Hematology
By:CGT GlobalviaBusiness Wire August 14, 2025 at 09:00 AM EDT CGT Global, a biotechnology leader accelerating access to life-changing cell and gene therapies, today announced the appointment of Jerome Ritz, MD, to its Board of Advisors. Dr. Ritz brings a distinguished career in hematology, oncology, cell manufacturing, and the advancement of cell and gene therapies.…
For More Information